Retina Lasers in Ophthalmology: Clinical Insights and Advancements

​Andrzej Grzybowski, M.D., Ph.D., MBA, MAE is a Professor of Ophthalmology and Chair of the Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland; Head of Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland. He is active in international scientific societies including Euretina (Co-opted Board member 2016-2018), Retina Society, AAO (International Fellow; member of the Global ONE Advisory Board 2017-2022, Museum of Vision's Program Committee 2017-2022, and member of the Task Force On Myopia), EVER (Board member and chair of the cataract section, 2019-2023; President-Elect 2022-2023), ESCRS (curator of ESCRS Archive), and ISRS (member of the ISRS International Council), ISBCS, International Council of Ophthalmology (program coordinator for WCO in 2011-2018), and Cogan Society. He became a lifelong member (chair LIV) of the European Academy of Ophthalmology and its Treasurer. He is a member of the Ophthalmic Education Consortium (OEC) advisory committee of the Ophthalmology Foundation and Academia Europea. He has been an active contributor to major ophthalmic conferences worldwide, including AAO (Achievement Award 2017, International Scholar Award 2018), APAO (International Coordinator 2017-2020, Achievement Award 2018), WCO (Program Coordinator 2010-2018), CCOS, Euretina, ESCRS, EVER, ISOPT, etc. He is the member of the Academia Europea.He has been an active editor, editor in chief, and author of more than 500 peer-reviewed international publications, and over 50 book chapters; reviewer for more than 20 journals. He is a member of the editorial boards of many international journals, including the American Journal of Ophthalmology (IF 5.5), Acta Ophthalmologica (IF 3.1), PLOS One (IF 3.75), Graefe's Archive for Clinical and Experimental Ophthalmology (IF 2,3), Translational Vision Science & Technology (TVST), (IF 3.048), BMC Ophthalmology (2.086), Clinics in Dermatology (IF 2.797), Journal of Clinical Medicine (IF 4.964), Current Pharmaceutical Design (IF 2.94), Frontiers in Neurology (IF 4.086), Asia Pacific Academy of Ophthalmology Journal (IF 4.206), Ophthalmology and Therapy (IF 4.9). Reviewer and member of Cochrane Collaboration.
As the only Polish ophthalmologist he was included in the TOP 2% ranking of world-best scientists prepared by Stanford University for 2019 and 2020. Expertscape worldwide ranking: No 1 in cataract field and No 1 in cataract extraction field. In 2021, he received ISRS (International Society for Refractive Surgery) Founders' Award and published a book Artificial Intelligence in Ophthalmology (Springer). In 2022 he was awarded OFFICERS' CROSS OF THE ORDER OF POLONIA RESTITUTA for outstanding achievements in research and teaching, and support for international scientific cooperation by the President of Poland; listed on the "The Power List" by The Ophthalmologist magazine, a ranking of the Top 100 most influential people in the world of ophthalmology, and awarded by Marshal of Warmia and Mazury Region "The best of the best" recognition for scientific achievements.
Jeffrey K Luttrull M.D. is a consultant retina specialist and internationally recognized innovator in the treatment of retinal diseases. His contributions, including "high-density / low-intensity subthreshold diode microsecond pulsed laser" (SDM), are advancing the treatment and understanding of retinal disease. Dr Luttrull is the most published and most frequently cited author in the field of retinal laser treatment. Through his research, Dr. Luttrull has been a pioneer in early and preventive treatment of diabetic retinopathy and developer of first preventive treatments for age-related macular degeneration that reduce the riskof "wet" macular degeneration and slow progression of age-related geographic atrophy to reduce the risks of visual loss. This new approach to disease prevention is called "Vision Protection TherapyTM", working via therapeutic Immunoactivation - engaging the body's own immune system to safely and effectively reduce the risks of vision loss.

Dr. Luttrull is a life member of the American Academy of Ophthalmology; an "Honor Award" recipient of the American Society of Retinal Specialists; founder of the Ventura County Ophthalmology Society; the founder and executive director of LIGHT: The International Retinal Laser Society; and the founder and chief medical officer of the Vision Protection Institutes.

Igor Kozak MD, PhD is a consultant ophthalmic surgeon and clinical lead at Moorfields Eye Hospital Centre, Abu Dhabi, United Arab Emirates. Dr Kozak is a graduate of Pavol Jozef Safárik University in Slovakia and is a fellowship-trained retina and uveitis specialist from the University of California San Diego Shiley Eye Institute, where he served on the retina faculty. He is currently a consultant ophthalmic surgeon and a clinical lead at the Moorfields Eye Hospital Centre in Abu Dhabi, United Arab Emirates, where he attends to patients with retinal and inflammatory problems and performs vitreoretinal surgery on adults and children.

Dr. Kozak's academic interests include clinical research, ocular imaging, drug delivery, and pharmacology. He has participated in numerous clinical trials and has been principal investigator in some. He has published extensively in premier ophthalmic and scientific journals and has edited 6 ophthalmic books internationally. He serves as a scientific reviewer for more than 50 ophthalmology journals and is an editorial board member for 4 journals.

Andrzej Grzybowski博士是波蘭奧爾什丁溫馬茲里大學眼科學教授，並擔任眼科學系主任；同時也是波茲南眼科發展基金會眼科研究所的所長。他活躍於國際科學社團，包括Euretina（2016-2018年任職董事會成員）、Retina Society、AAO（國際會員；2017-2022年全球ONE諮詢委員會成員、2017-2022年視覺博物館計劃委員會成員，以及近視工作小組成員）、EVER（董事會成員兼白內障部門主席，2019-2023年；2022-2023年當選主席）、ESCRS（ESCRS檔案館館長）和ISRS（ISRS國際理事會成員）、ISBCS、國際眼科學會（2011-2018年WCO計劃協調員）和Cogan學會。他成為歐洲眼科學院終身會員（LIV主席）和財務主管。他是眼科學基金會和歐洲學院眼科學教育聯盟（OEC）諮詢委員會的成員。他是全球主要眼科會議的活躍貢獻者，包括AAO（2017年成就獎，2018年國際學者獎）、APAO（2017-2020年國際協調員，2018年成就獎）、WCO（2010-2018年計劃協調員）、CCOS、Euretina、ESCRS、EVER、ISOPT等。他是歐洲學院的成員。他是500多篇同行評審的國際出版物和50多篇專書的編輯、主編和作者；他是20多個期刊的審稿人。他是許多國際期刊的編輯委員會成員，包括《美國眼科學雜誌》（IF 5.5）、《眼科學報》（IF 3.1）、PLOS One（IF 3.75）、《格拉夫眼科臨床與實驗眼科學》（IF 2.3）、《轉化視覺科學與技術》（TVST）（IF 3.048）、BMC眼科學（2.086）、《皮膚科臨床》（IF 2.797）、《臨床醫學雜誌》（IF 4.964）、《當代藥物設計》（IF 2.94）、《神經學前沿》（IF 4.086）、亞太眼科學院雜誌（IF 4.206）、眼科學與治療（IF 4.9）。他是Cochrane合作組織的審稿人和成員。作為唯一的波蘭眼科醫生，他被斯坦福大學列入2019年和2020年全球最佳科學家排名的前2%。Expertscape全球排名：白內障領域第一，白內障手術領域第一。2021年，他獲得了國際屈光手術學會（ISRS）創始人獎，並出版了一本名為《眼科中的人工智能》（Springer）的書。2022年，他獲得了波蘭總統頒發的波蘭復興勳章官佐十字勳章，以表彰他在研究和教學方面的傑出成就，以及對國際科學合作的支持；他被《眼科學家》雜誌列入“權力榜單”，該榜單是全球眼科學界最具影響力的100位人物排名，並獲得了Warmia和Mazury地區的馬紹爾頒發的“最佳的最佳”獎，以表彰他的科學成就。Jeffrey K Luttrull博士是顧問視網膜專家，也是治療視網膜疾病方面國際知名的創新者。他的貢獻，包括“高密度/低強度亞閾值二極管微秒脈衝激光”（SDM），正在推動視網膜疾病的治療和理解。Luttrull博士是視網膜激光治療領域中發表文章最多且被引用最頻繁的作者。通過他的研究，Luttrull博士在糖尿病視網膜病變的早期和預防治療方面是先驅者，並開發了第一個預防性治療老年性黃斑變性的方法，以減少“濕性”黃斑變性的風險，並減緩老年性地理性萎縮的進展，以減少視力損失的風險。